Postoperative parathyroid hormone levels as a predictor for persistent hypoparathyroidism.

Area of Science:

• Endocrinology
• Surgical Oncology
• Metabolic Disorders

Background:

• Hypoparathyroidism is a frequent complication following thyroidectomy.
• Predicting persistent hypoparathyroidism in individual patients remains challenging.
• Early identification of at-risk patients is crucial for timely intervention.

Purpose of the Study:

• To evaluate if a decrease in parathyroid hormone (PTH) levels on postoperative day one can predict persistent hypoparathyroidism one year after thyroidectomy.
• To identify a reliable biomarker for persistent hypoparathyroidism post-thyroidectomy.

Main Methods:

• Prospective, multi-center cohort study design.
• Inclusion of patients undergoing total or completion thyroidectomy.
• Measurement of preoperative and postoperative (day 1) PTH levels.
• Definition of persistent hypoparathyroidism as the need for calcium supplementation at one-year follow-up.

Main Results:

• A decrease in PTH levels >70% on postoperative day one was observed in 32 patients.
• All 14 patients (17.3%) with persistent hypoparathyroidism at one year had a >70% PTH decrease.
• None of the 49 patients without a >70% PTH decrease developed persistent hypoparathyroidism (P<0.001).
• The >70% PTH decrease demonstrated 100% sensitivity and 73.1% specificity for predicting persistent hypoparathyroidism.

Conclusions:

• A >70% decrease in PTH levels post-thyroidectomy is a strong predictor of persistent hypoparathyroidism.
• This biomarker can aid in risk stratification for patients after thyroid surgery.
• Further validation in larger cohorts is recommended.